Intensive treatment may delay microvascular complicationsBut the approach comes at the cost of increased mortality, ACCORD trial shows Type 2 drug helps adults with type 1 diabetesPatients with inadequate glycemic control saw reductions in blood glucose and HbA1c levels, lowered insulin use Check for eating disorders in female type 1 diabetics Patterns in HbA1c, hypoglycemic episodes and menses can offer clues Statins underused in diabetics U.S. researcher calls for more integrated approach to treating hyperglycemia and dyslipidemia to lower cardiovascular risks Dialing up diabetes data Sensor-augmented insulin pump pays off in type 1 diabetes Technology helps patients of all ages reach HbA1c targets by monitoring blood-glucose trends Guide to OTC Health Management: Diabetes and lifestyle Using food and fitness to manage diabetes FDA committees split on rosiglitazone Market withdrawal is most popular option, but not a majority vote Team care model for diabetes gaining support Division of tasks among care providers makes use of specialized training to improve patients’ understanding Rosiglitazone controversy continues to smolder First Previous 56 57 58 59 60 Next Last
